Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, Black Diamond Therapeutics (BDTX) shares jumped nearly 8%. The company and French pharmaceutical group Servier said Wednesday that they have signed a global licensing deal under which Servier will develop and globally commercialize BDTX-4933, a targeted therapy for solid tumors.
OmniAb (OABI) shares dropped 20% after it reported a Q4 net loss late Tuesday and gave 2025 revenue guidance that missed analysts' estimates.
Amarin (AMRN) shareholder JEC Capital Partners and some of its affiliates urged the company's board in an open letter Wednesday to undergo a strategic review to maximize shareholder value. Amarin shares popped past 6%.
HealthEquity (HQY) shares tumbled past 17% after its fiscal Q4 earnings fell short of market estimates, while it raised the top end of its full-year revenue outlook.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.